CUAMC
VIR icon

China Universal Asset Management Company’s Vir Biotechnology VIR Stock Holding History

China Universal Asset Management Company’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Sell
26,841
-1,049
-4% -$9.98K 0.02% 330
2026
Q1 		$250K Buy
27,890
+5,220
+23% +$41.6K 0.02% 332
2025
Q4 		$137K Sell
22,670
-1,680
-7% -$10K 0.01% 383
2025
Q3 		$139K Sell
24,350
-3,415
-12% -$17.5K 0.01% 359
2025
Q2 		$140K Buy
27,765
+256
+0.9% +$1.37K 0.01% 339
2025
Q1 		$178K Sell
27,509
-1,693
-6% -$15.1K 0.02% 322
2024
Q4 		$214K Buy
29,202
+2,922
+11% +$23K 0.02% 321
2024
Q3 		$197K Buy
26,280
+10,294
+64% +$89.4K 0.02% 300
2024
Q2 		$142K Sell
15,986
-9,988
-38% -$95.8K 0.02% 274
2024
Q1 		$263K Buy
25,974
+10,414
+67% +$106K 0.03% 257
2023
Q4 		$157K Buy
15,560
+12,112
+351% +$111K 0.03% 231
2023
Q3 		$32.3K Buy
3,448
+1,692
+96% +$24.1K 0.01% 261
2023
Q2 		$43.1K Sell
1,756
-53
-3% -$1.33K 0.01% 206
2023
Q1 		$42.1K Buy
1,809
+456
+34% +$11.7K 0.01% 163
2022
Q4 		$34.2K Buy
1,353
+111
+9% +$2.72K 0.01% 149
2022
Q3 		$24K Buy
+1,242
New +$31.6K 0.01% 146

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

China Universal Asset Management Company's VIR Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Vir Biotechnology (VIR) stake by 3.8% in Q2 2026, selling an estimated $9.98K and leaving 26,841 shares worth $274K. The position accounts for 0.02% of the portfolio, ranked #330.

China Universal Asset Management Company first reported a position in VIR in Q3 2022 and has held it in 16 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • China Universal Asset Management Company held 26,841 shares of Vir Biotechnology worth $274K as of Q2 2026.
  • China Universal Asset Management Company sold 1,049 Vir Biotechnology shares in Q2 2026, an estimated $9.98K.
  • Vir Biotechnology made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #330 holding.
  • China Universal Asset Management Company first reported a position in Vir Biotechnology in Q3 2022 and has held it in 16 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.